Precision BioSciences (DTIL) Tops Q1 EPS by 181c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of $1.70, $1.81 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.58 million versus the consensus estimate of $8.83 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat